- Home
- PBF vs PTGX Comparison
PBF vs PTGX Comparison
Compare PBF & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBF
- PTGX
- Stock Information
- Founded
- PBF 2008
- PTGX 2006
- Country
- PBF United States
- PTGX United States
- Employees
- PBF N/A
- PTGX N/A
- Industry
- PBF Integrated oil Companies
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- PBF Energy
- PTGX Health Care
- Exchange
- PBF Nasdaq
- PTGX Nasdaq
- Market Cap
- PBF 3.3B
- PTGX 3.7B
- IPO Year
- PBF 2012
- PTGX 2016
- Fundamental
- Price
- PBF $27.96
- PTGX $59.36
- Analyst Decision
- PBF Hold
- PTGX Strong Buy
- Analyst Count
- PBF 14
- PTGX 8
- Target Price
- PBF $26.14
- PTGX $70.13
- AVG Volume (30 Days)
- PBF 3.9M
- PTGX 872.6K
- Earning Date
- PBF 10-30-2025
- PTGX 11-06-2025
- Dividend Yield
- PBF 3.84%
- PTGX N/A
- EPS Growth
- PBF N/A
- PTGX N/A
- EPS
- PBF N/A
- PTGX 0.80
- Revenue
- PBF $30,275,300,000.00
- PTGX $209,180,000.00
- Revenue This Year
- PBF N/A
- PTGX N/A
- Revenue Next Year
- PBF $5.91
- PTGX $185.11
- P/E Ratio
- PBF N/A
- PTGX $74.07
- Revenue Growth
- PBF N/A
- PTGX N/A
- 52 Week Low
- PBF $13.62
- PTGX $33.31
- 52 Week High
- PBF $34.31
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- PBF 57.56
- PTGX 55.65
- Support Level
- PBF $27.53
- PTGX $54.50
- Resistance Level
- PBF $31.06
- PTGX $61.04
- Average True Range (ATR)
- PBF 1.59
- PTGX 2.71
- MACD
- PBF 0.14
- PTGX -0.05
- Stochastic Oscillator
- PBF 54.00
- PTGX 64.07
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.